ATE1067T1 - Ein isoxazolderivat, verfahren zu seiner herstellung und diese verbindung enthaltende mittel. - Google Patents

Ein isoxazolderivat, verfahren zu seiner herstellung und diese verbindung enthaltende mittel.

Info

Publication number
ATE1067T1
ATE1067T1 AT79105142T AT79105142T ATE1067T1 AT E1067 T1 ATE1067 T1 AT E1067T1 AT 79105142 T AT79105142 T AT 79105142T AT 79105142 T AT79105142 T AT 79105142T AT E1067 T1 ATE1067 T1 AT E1067T1
Authority
AT
Austria
Prior art keywords
compound
production
compositions containing
isoxazole derivative
isoxazole
Prior art date
Application number
AT79105142T
Other languages
German (de)
English (en)
Inventor
Friedrich-Johannes Dr. Kaemmerer
Rudolf Dr. Schleyerbach
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Application granted granted Critical
Publication of ATE1067T1 publication Critical patent/ATE1067T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT79105142T 1978-12-16 1979-12-13 Ein isoxazolderivat, verfahren zu seiner herstellung und diese verbindung enthaltende mittel. ATE1067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782854439 DE2854439A1 (de) 1978-12-16 1978-12-16 Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
EP79105142A EP0013376B1 (de) 1978-12-16 1979-12-13 Ein Isoxazolderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Mittel

Publications (1)

Publication Number Publication Date
ATE1067T1 true ATE1067T1 (de) 1982-06-15

Family

ID=6057414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79105142T ATE1067T1 (de) 1978-12-16 1979-12-13 Ein isoxazolderivat, verfahren zu seiner herstellung und diese verbindung enthaltende mittel.

Country Status (25)

Country Link
US (2) US4284786A (OSRAM)
EP (1) EP0013376B1 (OSRAM)
JP (1) JPS5583767A (OSRAM)
AR (2) AR222680A1 (OSRAM)
AT (1) ATE1067T1 (OSRAM)
AU (1) AU529341B2 (OSRAM)
BG (1) BG60764B2 (OSRAM)
CA (1) CA1129867A (OSRAM)
DE (2) DE2854439A1 (OSRAM)
DK (1) DK149886C (OSRAM)
EG (1) EG13926A (OSRAM)
ES (2) ES486750A1 (OSRAM)
FI (1) FI64154C (OSRAM)
GR (1) GR72731B (OSRAM)
HU (1) HU178015B (OSRAM)
IE (1) IE49126B1 (OSRAM)
IL (1) IL58951A (OSRAM)
LU (1) LU90466I2 (OSRAM)
MX (2) MX6174E (OSRAM)
NL (1) NL990037I2 (OSRAM)
NO (1) NO148925C (OSRAM)
NZ (1) NZ192400A (OSRAM)
PH (1) PH16627A (OSRAM)
PT (1) PT70596A (OSRAM)
ZA (1) ZA796793B (OSRAM)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2538806B1 (fr) * 1982-12-30 1986-02-21 Bago Sa Labor Composes phenyl-3 methyl isoxazole-5 carboxy-4 anilides substitues, actifs therapeutiquement contre l'inflammation et la douleur
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
US4935434A (en) * 1988-01-26 1990-06-19 Bristol-Myers Company Antiarthritic isoxazole-4-carboxamides
FR2662692B1 (fr) * 1990-05-30 1995-04-28 Novapharme Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
KR100188801B1 (ko) * 1990-05-18 1999-06-01 엥겔하르트 라피체 이속사졸-4카복스아미드 및 하이드록시알킬리덴 시아노아세트아미드 및 이들 화합물을 함유하는 약제학적 조성물
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
ES2124800T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
ES2124801T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
ATE174220T1 (de) * 1993-01-08 1998-12-15 Hoechst Ag Verwendung von leflunomid zur hemmung von interleukin 8
EP0607774B1 (de) * 1993-01-08 1998-12-09 Hoechst Aktiengesellschaft Verwendung von Leflunomid zur Hemmung von Interleukin 1 alpha
TW314467B (OSRAM) * 1993-03-31 1997-09-01 Hoechst Ag
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
LT3589B (en) 1993-11-30 1995-12-27 Hoechst Ag Using of known combination for treatment of rejection reaction by transplantation of organs
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
US5814649A (en) * 1994-10-17 1998-09-29 Hoechst Pharmaceuticals & Chemicals K.K. Preventive and remedy for type 1 allergic diseases
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
PT987256E (pt) * 1997-08-08 2002-03-28 Aventis Pharma Gmbh Forma cristalina da n-(4-trifluorometilfenil)-5-metil-isoxazol-4-carboxamida
US7691890B2 (en) 1998-03-11 2010-04-06 James W. Williams Anti-viral uses of leflunomide products
US20050255071A1 (en) * 1998-12-10 2005-11-17 Aventis Pharma Deutschland Gmbh Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
DE19908527C2 (de) 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
US6566395B1 (en) 1999-05-25 2003-05-20 Biomedicines, Inc. Methods of treating proliferative disorders
DE19960443C2 (de) * 1999-12-15 2002-05-08 Aventis Pharma Gmbh Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
CZ20022000A3 (cs) * 1999-12-16 2003-02-12 Teva Pharmaceuticals Industries Ltd. Způsoby přípravy a nová krystalická forma leflunomidu
EP1473035A1 (en) * 2000-02-15 2004-11-03 Teva Pharmaceutical Industries Ltd. Leflunomide of high purity
JP2004500380A (ja) 2000-02-15 2004-01-08 テバ　ファーマシューティカル　インダストリーズ　リミティド レフルノミドの合成方法
AU2001284891A1 (en) * 2000-08-14 2002-02-25 Teva Pharmaceutical Industries Ltd. Micronized leflunomide
PT1381356E (pt) 2001-04-05 2008-07-24 Aventis Pharma Inc Utilização de (4' -trifluorometilfenil) - amida do ácido (z) -2- ciano-3-hidroxi-but-2-enóico para tratamento da esclerose múltipla
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US20030139606A1 (en) * 2001-11-09 2003-07-24 Ray Anup Kumar Process for preparing 5-methylisoxazole-4-carboxylic- (4'-trifluoromethyl)-anilide
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
JPWO2007026737A1 (ja) * 2005-08-31 2009-03-12 興和株式会社 関節リウマチの予防及び／又は治療法
EP2125895B1 (en) 2007-02-02 2015-04-08 Vegenics Pty Ltd Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis
CN101817797B (zh) * 2009-02-26 2013-04-10 江苏亚邦爱普森药业有限公司 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) * 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US11202853B2 (en) * 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
JP2021519334A (ja) 2018-03-26 2021-08-10 クリア クリーク バイオ， インコーポレイテッド ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法
CA3145269A1 (en) 2019-07-22 2021-01-28 Michel BURCKLEN Use of ponesimod for the treatment of multiple sclerosis
AU2021232637A1 (en) 2020-03-06 2022-09-22 Actelion Pharmaceuticals Ltd Methods of slowing brain volume loss
US20210300873A1 (en) 2020-03-20 2021-09-30 Clear Creek Bio, Inc. Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
WO2023062511A1 (en) 2021-10-11 2023-04-20 Actelion Pharmaceuticals Ltd Methods of treating multiple sclerosis
WO2023061935A1 (en) 2021-10-11 2023-04-20 Actelion Pharmaceuticals Ltd Methods of treating multiple sclerosis
CA3220702A1 (en) 2022-02-11 2023-08-17 Actelion Pharmaceuticals Ltd Methods of slowing an increase in brain ventricular volume

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087534A (en) * 1974-05-22 1978-05-02 David Ovadia N-haloalkylmio urazole pesticides
DE2524959C2 (de) * 1975-06-05 1983-02-10 Hoechst Ag, 6000 Frankfurt 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel
ES448386A1 (es) * 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten

Also Published As

Publication number Publication date
NO148925B (no) 1983-10-03
IE49126B1 (en) 1985-08-07
DK149886C (da) 1987-04-21
EP0013376B1 (de) 1982-05-19
AU5385379A (en) 1980-06-19
EP0013376A2 (de) 1980-07-23
MX6174E (es) 1984-12-04
GR72731B (OSRAM) 1983-12-01
ES486758A1 (es) 1980-05-16
ES486750A1 (es) 1980-06-16
JPH0133470B2 (OSRAM) 1989-07-13
IE792426L (en) 1980-06-16
FI64154C (fi) 1983-10-10
PH16627A (en) 1983-12-05
JPS5583767A (en) 1980-06-24
AR226894A1 (es) 1982-08-31
NL990037I1 (nl) 2000-01-03
NO148925C (no) 1984-01-11
MX8403A (es) 1994-03-31
LU90466I2 (fr) 2000-01-03
ZA796793B (en) 1980-11-26
EP0013376A3 (en) 1980-09-17
CA1129867A (en) 1982-08-17
BG60764B2 (bg) 1996-02-29
FI64154B (fi) 1983-06-30
AU529341B2 (en) 1983-06-02
US4284786A (en) 1981-08-18
DK149886B (da) 1986-10-20
FI793899A7 (fi) 1980-06-17
IL58951A0 (en) 1980-03-31
EG13926A (en) 1982-09-30
NO794094L (no) 1980-06-17
PT70596A (de) 1980-01-01
US4351841A (en) 1982-09-28
DK534279A (da) 1980-06-17
HU178015B (en) 1982-02-28
IL58951A (en) 1984-01-31
DE2854439A1 (de) 1980-07-03
NL990037I2 (nl) 2000-01-03
DE2962929D1 (en) 1982-07-08
NZ192400A (en) 1982-02-23
AR222680A1 (es) 1981-06-15

Similar Documents

Publication Publication Date Title
ATE1067T1 (de) Ein isoxazolderivat, verfahren zu seiner herstellung und diese verbindung enthaltende mittel.
ATE29T1 (de) Pyrazolaetherderivate, verfahren zu ihrer herstellung und herbizide, die diese verbindungen enthalten
ATE7910T1 (de) Substituierte iminodisaeuren, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IT8019049A0 (it) Composti 2 penem, metodo per laloro preparazione e composizioni farmaceutiche contenenti tali composti.
ATE10938T1 (de) Cyclohexandionderivate, verfahren zu ihrer herstellung und diese enthaltende herbizide.
PT69058A (de) 1,2,4-oxadiazolderivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
NL188265C (nl) Werkwijze ter bereiding van reukstofcomposities.
PT67442A (de) Thiazolylzimtsaeurenitrile,schaedlingsbekaempfungsmittel enthaltende,diese verbindungen sowie verfahren zu ihrer herstellung
ATE9895T1 (de) 1-phenyl-2-cyclohexen-1-alkylamin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
FI791424A7 (fi) Substituoidut 8-hydroksi-1-fenyyli-2,3,4,5-tetrahydro-1H-3- bentsatsepiinit, menetelmä niiden valmistamiseksi jniitä sisältävät farmaseuttiset seokset.
FI793445A7 (fi) Menetelmä uusien, aryylitrifluorietanolia sisältävien farmaseuttisten koostumusten valmivalmistamiseksi.
ATE14309T1 (de) Pyrazolinderivate, verfahren zu ihrer herstellung und diese enthaltende insektizide praeparate.
LU79168A1 (de) Benzylpyrimidine,verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATA213579A (de) Verfahren zur herstellung von neuen, diuretisch wirksamen steroid-spiro- oxazolidinon-derivaten en und von aus diesen verbindungen bereiteten arznei- mitteln
EP0069154A4 (en) Novel thiazole compounds, process for their preparation, and medicinal composition containing same.
DE3483628D1 (de) 1,n-diaryl-4,5-dihydro-1h-pyrazol-3-amine, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
PT65544A (de) Substituierte sulfoximide,verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ATE7027T1 (de) Substituierte tetrahydropyrimidinonderivate, verfahren zu ihrer herstellung und herbizide, die diese derivate als wirkstoffe enthalten.
DD134789A1 (de) Maschenlaufgehemmtes polschlingengewirke,verfahren und haekelgalonmaschine zu seiner herstellung
DE3773240D1 (de) Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
LU80659A1 (de) Neue pyrido-pyrimidine,verfahren zu ihrer herstellung und diese verbindungen enthaltenden arzneimittel
PT65482A (de) Neue 2,4-diamino-5-benzypyrimidine,verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
NL7502124A (nl) Werkwijze ter bereiding van reuk- en smaakstof- composities, alsmede ter bereiding van als reuk- en smaakstof bruikbare verbindingen.
PT67170B (de) Lactame verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
LU79710A1 (de) Furancarbonsaeureanilide,fungizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung